Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan and Paclitaxel in Recurrent/Metastatic Cervical Cancer
NCT00003065Phase 2Completed
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Jan 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan, paclitaxel in Cervical Cancer (CC), sponsored by Herbert Irving Comprehensive Cancer Center. Started Jan 1997; status: completed.
02
Drugs
topotecanpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00003065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003065.